Signal transduction by vascular endothelial growth factor receptors
2011 (English)In: Biochemical Journal, ISSN 0264-6021, E-ISSN 1470-8728, Vol. 437, 169-183 p.Article, review/survey (Refereed) Published
VEGFs (vascular endothelial growth factors) control vascular development during embryogenesis and the function of blood vessels and lymphatic vessels in the adult. There are five related mammalian ligands, which act through three receptor tyrosine kinases. Signalling is modulated through neuropilins, which act as VEGF co-receptors. Heparan sulfate and integrins are also important modulators of VEGF signalling. Therapeutic agents that interfere with VEGF signalling have been developed with the aim of decreasing angiogenesis in diseases that involve tissue growth and inflammation, such as cancer. The present review will outline the current understanding and consequent biology of VEGF receptor signalling.
Place, publisher, year, edition, pages
2011. Vol. 437, 169-183 p.
angiogenesis, internalization, neuropilin, signal transduction, vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor (VEGFR)
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-157130DOI: 10.1042/BJ20110301ISI: 000293156500001OAI: oai:DiVA.org:uu-157130DiVA: diva2:435211